ReviewCancers2021

Adjuvant Treatment with Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Non-Small-Cell Lung Carcinoma Patients, Past, Present and Future.

Walid Shalata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.